Phenytoin API molecular structure visualization
CNS & Neurological API

Phenytoin API

A premium hydantoin-derivative anticonvulsant structurally engineered to stabilize neuronal membranes and effectively treat diverse seizure disorders.

CAS Number

57-41-0

Formula

C₁₅H₁₂N₂O₂

Mol. Weight

252.27 g/mol

Grade

BP / EP / USP

USFDA DMF Filed
USP / EP / BP Tested
Export Ready (45+ Countries)
Standard Care Protocol

Product Overview

Phenytoin is a highly effective, legacy hydantoin-derivative anticonvulsant heavily relied upon in global epilepsy treatment protocols. By profoundly stabilizing neuronal membranes and regulating sodium channel mechanics, it controls extreme neuronal excitability, making it the bedrock therapeutic standard for resolving both complex partial and tonic-clonic seizures.

As a global pharmaceutical leader, Jay Overseas guarantees reliable sourcing of this essential API. We distribute Phenytoin derived purely from state-of-the-art WHO-GMP certified facilities with complete regulatory profiles, extending our reliable supply chain network into the most demanding regulatory markets.

Crystalline Integrity

Consistently controlled particle morphology yielding robust API compaction.

Formulation Agnostic

Easily adaptable into solid oral systems or stable suspension mediums.

API Snapshot

CAS Number57-41-0
Molecular FormulaC₁₅H₁₂N₂O₂
GradeUSP / EP / BP
Shelf Life36–60 Months
Storage Temp15–30°C
Request Compliance Data →

Mechanism of Action

01

Membrane Stabilization

Phenytoin physically stabilizes neuronal membranes by modulating voltage-gated sodium channels.

02

Inactive State Prolongation

It significantly prolongs the inactive state of these sodium channels, throttling the ability of specific neurons to fire repetitively at high frequency.

03

Action Potential Inhibition

This targeted blocking halts the erratic spread of seizure activity and decisively prevents the propagation of abnormal electrical discharges throughout the brain.

Therapeutic Targets

Therapeutic Applications

01

Generalized Seizures

Primary treatment vector for generalized tonic-clonic (grand mal) seizures.

02

Partial Seizures

Effective management of complex partial seizures providing steady neuro-inhibition.

03

Status Epilepticus

Emergency therapeutic alternative in injectable form for profound status epilepticus.

04

Neurological Prophylaxis

Prevention and treatment of seizures following severe head trauma or neurosurgery.

Competitive Edge

Clinical Advantages & Value Proposition

Phenytoin provides unparalleled seizure suppression via sodium channel modulation across multiple established treatment protocols.

Long half-life (average 22 hours) allows convenient once or twice daily dosing

Highly cost-effective anticonvulsant therapy option globally

Available and stable in multiple formulation forms (tablets, capsules, suspension, injection)

Extensive clinical experience spanning decades with predictable pharmacokinetic profiling

Non-sedating at properly maintained therapeutic doses

Broadly effective for multiple seizure types including tonic-clonic and focal seizures

Manufacturing Excellence

Our Phenytoin API is manufactured in state-of-the-art WHO-GMP certified facilities applying robust continuous process controls. Our compliance framework aligns universally with global pharmacopoeial standards, guaranteeing an unbroken supply line with uncompromising precision for our B2B partners.

Certificate of Analysis (COA)Drug Master File (DMF)GMP CertificatesStability ReportsValidation Reports

Export Status

45+ Countries (Globally)

Documentation

Complete Technical Pack

Analytical Data

Detailed Specifications

Rigidly Compliant with Standard Pharmacopoeia (USP / EP / BP)

Sr.Test ParameterGlobal Specification Validation
1DescriptionWhite or almost white, crystalline powder
2SolubilityPractically insoluble in water, soluble in hot alcohol, soluble in dilute alkali
3IdentificationIR spectrum conforms; Melting point 295-298°C; Positive color reaction for hydantoins
4Melting Point295°C – 298°C
5Loss on DryingNot more than 0.5% (105°C, 3 hours)
6Related Substances (HPLC)5,5-Diphenylhydantoin: NMT 0.3%, Benzophenone: NMT 0.2%, Individual impurity: NMT 0.10%, Total: NMT 1.0%
7Residue on IgnitionNot more than 0.1%
8Heavy MetalsNMT 20 ppm
9Residual SolventsComplies with ICH Q3C guidelines (Class 2 & 3 solvents)
10ChlorideNMT 200 ppm
11Assay (Titrimetry, dried)99.0% – 101.0% (calculated as C₁₅H₁₂N₂O₂)
12Microbial LimitsTAMC: NMT 1000 CFU/g, TYMC: NMT 100 CFU/g, E. coli & Salmonella: Absent
13Particle Size DistributionAs per customer requirement
Global Partnership

Why Choose Our Phenytoin API

Regulatory Excellence

Products sourced from facilities with USFDA DMF filed, WHO-GMP certified, with full compliance to BP, EP, and USP standards.

Pharmaceutical Grade Quality

Consistent high-purity API with stringent impurity control and complete analytical documentation for each batch.

Reliable Global Supply

Consistent availability with efficient logistics to 45+ countries, backed by our extensive pharmaceutical trading network.

Complete Documentation

Full technical packages available including DMF access, multi-zone stability data, and detailed Certificate of Analysis (CoA).

Related CNS APIs

Packaging Standard

Double LDPE/HDPE inner bags secured inside robust fiber drums with inner liner. Available in 5 kg, 10 kg, and 25 kg pack sizes. Custom packing available.

Storage Protocol

Store at controlled room temperature 15–30°C (59–86°F). Must be protected from light and moisture and kept securely tightly closed.

Validated Shelf Life

Comprehensive stability data confirms an extended shelf life of 36-60 months when stored strictly under the recommended ambient conditions.

Ready to Source Top-Tier API?

Contact our technical and commercial team for prompt dispatch of samples, competitive pricing, and full regulatory document support.

Legal Disclaimer: Phenytoin is a highly regulated therapeutic substance in most global jurisdictions. The product documentation, CoAs, and regulatory support detailed above are exclusively available for licensed pharmaceutical manufacturing entities and authorized research divisions under proper legal importation compliances. This API is not a finished dosage form.